Medtronic to Establish Innovation Center in Chengdu
October 10 2017 - 1:00AM
YASTEST
Facilitating
Clinical Training for Physicians and Advancing Local Healthcare
Efficiency in Central and Western China
DUBLIN and CHENGDU, Sichuan -
October 10, 2017 - Medtronic plc (NYSE:MDT) today announced the
groundbreaking of its Chengdu Innovation Center at the
Singapore-Sichuan Hi-Tech Innovation Park in Sichuan Province. Set
to open in 2020, this center will provide a leading,
cross-disciplinary clinical training and research platform for
medical workers in Sichuan and other central and western regions.
Liu Liedong, vice mayor of Chengdu, Omar Ishrak, chairman and CEO
of Medtronic, and Chris Lee, president of Medtronic Greater China,
attended the groundbreaking ceremony alongside a host of honored
guests.
"Medtronic understands the critical role that
rural physicians play in driving the healthcare availability and
transformation," said Omar Ishrak. "As such, we hope to support the
growth and development of medical workers in China's vast central
and western regions, help them better understand, grasp and
capitalize the frontier technologies, enhance their clinical skills
to benefit more patients, and move forward together toward the
Healthy China goal."
Despite increased investment in clinical training
for China's healthcare professionals, clinical training for Chinese
physicians, in particular those in the country's western regions,
remains insufficient. The lack of effective training has led to an
average 10-year gap between the maturation period of Chinese
physicians and those in developed countries1.
Furthermore, data from the "China Health and Family Planning
Statistical Yearbook 2016" shows that the number of on-the-job
medical training organizations in China's western regions totaled
only 89 in 2015, or half that of the country's eastern
regions2. The
availability of clinical training has become a major challenge for
China in cultivating professional and skilled medical workers.
To facilitate the development of medical workers,
Medtronic aims to build the Chengdu Innovation Center into one of
the most advanced "one-stop" clinical training facilities in
Central and Western China at this moment. Leveraging Medtronic's
global-leading innovations and clinical expertise, this center will
provide world-class training programs across diverse disciplines,
including surgery, minimally invasive surgery, intensive care,
internal medicine and anesthetics, as well as disease areas such as
cardiovascular, tumors, respiratory, nervous system,
gastrointestinal, and renal diseases. The center will also be
equipped with cutting-edge simulation systems and equipment,
helping to improve clinical skills and increase learning efficiency
of medical workers through a highly-simulated training environment
and tiered training curriculums.
Within five years of operation, Medtronic projects
an annual training capacity of approximately 7,000 healthcare
professionals at the Chengdu center. Before Chengdu, Medtronic's
Shanghai Innovation Center has been operating for more than 10
years. Building upon this experience, the Chengdu center will help
to promote more extensive exchange and collaborative innovation
among healthcare professionals, medical service institutions and
research organizations by joining forces with Medtronic's global
Innovation Center network in Shanghai as well as Japan, Korea,
India, Turkey, and Brazil.
"Chengdu is actively fostering innovation within
the biopharmaceutical industry, and it's particularly important to
build an open and pragmatic innovation environment," said Liu
Liedong. "We hope that more international leading platforms, like
the Medtronic Innovation Center, can inspire innovation and become
a driving force in helping us explore local needs. In turn, we can
facilitate stronger connections and collaborations between
academia, research institutes, corporations, and the biopharma
industry, and enable clinical applications that help convert
technology into more valuable medical services."
Medtronic has been dedicated to promoting and
advancing local healthcare access, quality and innovation. With
this dedication in heart, Medtronic has collaborated with the
Chengdu Hi-Tech Industrial Development Zone on multiple investment
projects in recent years. Following the local hemodialysis and
insulin pump projects, the new Medtronic Innovation Center in
Chengdu will help to further improve local medical industry
capabilities boasting a stronger portfolio from research and
development to manufacturing innovative products to clinical
trainings and exchanges.
"The China market presents one of the greatest
opportunities for Medtronic," said Chris Lee. "We are ready and
eager to continue working with partners in China to explore and
solve the country's healthcare challenges. With the new Medtronic
Innovation Center in Chengdu, we will have more resources to
mobilize local medical workers to participate in key healthcare
initiatives, and eventually strengthen and advance the vital
healthcare industry through collective insights, expertise, and
skills."
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin,
Ireland, is among the world's largest medical technology, services
and solutions companies - alleviating pain, restoring health and
extending life for millions of people around the world. Medtronic
employs more than 84,000 people worldwide, serving physicians,
hospitals and patients in approximately 160 countries. The company
is focused on collaborating with stakeholders around the world to
take healthcare Further, Together.
Any forward-looking statements
are subject to risks and uncertainties such as those described in
Medtronic's periodic reports on file with the Securities and
Exchange Commission. Actual results may differ materially from
anticipated results.
-end-
1 People's
Daily: China kicks off standardized training for resident
doctors
http://www.nhfpc.gov.cn/qjjys/s3594/201502/5f572a83a2d7443c865b04e95f1bbfe6.shtml
2 China
Health and Family Planning Statistical Yearbook 2016
http://www.doc88.com/p-0062893629801.html
Contacts:
Demi Jiang
Public Relations
+86-21-2032-5322
Ryan Weispfenning
Investor Relations
+1-763-505-4626
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Medtronic plc via Globenewswire
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2023 to Apr 2024